Citations

Clear

390 citation(s) found for "Loftus, E".

The fate of indefinite and low-grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation
Eaton, John E. , Smyrk, Thomas C. , Imam, Mohamad , Pardi, Darrell S. , Loftus, Edward V. , Owens, Victoria , Talwalkar, Jayant A., Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | August 30, 2013 | Volume: 38 | Issue: 8 | Pages: 977-987

10.1111/apt.12469 | PMID 24033551 Get It

TROY (TNFRSF19) Promotes Glioblastoma Survival Signaling and Therapeutic Resistance
Loftus, Joseph C. , Tuncali, Serdar, Kloss, Jean , Schumacher, Cassie, Cao, Brian, Williams, Bart O. , Eschbacher, Jennifer , Ross, Julianna T.D., Tran, Nhan L. , Dhruv, Harshil , Yang, Zhongbo , Tran, Nhan L

Mayo Clinic

Molecular Cancer Research | May 23, 2013 | Volume: 11 | Issue: 8 | Pages: 865-874

10.1158/1541-7786.mcr-13-0008 | PMID 23699535 Get It

Abstract Of the features that characterize glioblastoma, arguably none is more clinically relevant than the propensity of malignant glioma cells to aggressively invade into the surrounding normal brain tissue. These invasive cells render complete resection impossible, confer significant resistance to chemo- and radiation-therapy, and virtually assure tumor recurrence. Expression of TROY (TNFRSF19), a member of the TNF receptor superfamily, inversely correlates with patient survival and stimulates glioblastoma cell migration and invasion in vitro. In this study, we report that TROY is overexpressed in glioblastoma tumor specimens and TROY mRNA expression is increased in the invasive cell population in vivo. In addition, inappropriate expression of TROY in mouse astrocytes in vivo using glial-specific gene transfer in transgenic mice induces astrocyte migration within the brain, validating the importance of the TROY signaling cascade in glioblastoma cell migration and invasion. Knockdown of TROY expression in primary glioblastoma xenografts significantly prolonged survival in vivo. Moreover, TROY expression significantly increased resistance of glioblastoma cells to both IR- and TMZ-induced apoptosis via activation of Akt and NF-κB. Inhibition of either Akt or NF-κB activity suppressed the survival benefits of TROY signaling in response to TMZ treatment. These findings position aberrant expression and/or signaling by TROY as a contributor to the dispersion of glioblastoma cells and therapeutic resistance. Implications: Targeting of TROY may increase tumor vulnerability and improve therapeutic response in glioblastoma. Mol Cancer Res; 11(8); 865–74. ©2013 AACR.
Adult‐onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo C
Podjasek, Joshua O., Loftus, Conor G., Smyrk, Thomas C. , Wieland, Carilyn N.

Mayo Clinic

International Journal of Dermatology | April 29, 2013 | Volume: 53 | Issue: 3 | Pages: 305-311

10.1111/j.1365-4632.2012.05716.x | PMID 23621577 Get It

AbstractBackgroundLangerhans cell histiocytosis (LCH) is frequently known to involve multiple organ systems. However, gastrointestinal involvement by LCH is rare.MethodsWe describe a 68‐year‐old woman with a 3‐year history of intermittent diarrhea initially diagnosed as inflammatory bowel disease. She was subsequently found to have systemic LCH with involvement of the gastrointestinal tract, lungs, liver, and skin after skin biopsy was performed. A retrospective review of patients with cutaneous involvement of LCH seen at the Mayo Clinic over the past 15 years was conducted. The presence of systemic disease as well as specific organ system involvement was reviewed.ResultsTwenty‐four patients with cutaneous LCH were identified. Besides our case, one other patient with both gastrointestinal and cutaneous involvement was identified. This patient died at six months of age. No other adult‐onset cases were identified.ConclusionsGastrointestinal involvement with LCH is rare, can be easily misdiagnosed, and likely portends a poor prognosis. In patients with ill‐defined systemic symptoms, cutaneous exam and biopsy have the potential to diagnose systemic disease.
Peripheral neuropathy incidence in inflammatory bowel disease
Figueroa, Juan J., Loftus, Edward V. , Harmsen, William S. , Dyck, P. James B. , Klein, Christopher J. , Klein, Christopher J , Loftus, Edward V

Mayo Clinic

Neurology | April 10, 2013 | Volume: 80 | Issue: 18 | Pages: 1693-1697

10.1212/wnl.0b013e3182904d16 | PMID 23576624 Get It

Meta‐analysis: serological markers and the risk of acute and chronic pouchitis
Singh, Siddharth , Sharma, Piyush Kumar , Loftus, Edward V. , Pardi, Darrell S. , Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | March 12, 2013 | Volume: 37 | Issue: 9 | Pages: 867-875

10.1111/apt.12274 | PMID 23480145 Get It

Summary Background Serological markers such as anti‐neutrophil cytoplasmic antibody ( ANCA ) and anti‐ S accharomyces cerevisiae antibody ( ASCA ) may be associated with pouchitis after ileal pouch‐anal anastomosis ( IPAA ). Aim To perform a systematic review with meta‐analysis of studies evaluating the association of ANCA and ASCA status with risk of acute and chronic pouchitis after IPAA . Methods We searched multiple databases (upto S eptember 2012) for studies reporting ANCA and/or ASCA status along with risk of acute or chronic pouchitis after IPAA in adults with ulcerative colitis ( UC ). We abstracted odds ratio ( OR ) or raw data from the individual studies to calculate summary OR estimates with 95% CI s using random‐effects model. Results Eight studies reporting 184 cases of acute pouchitis and six studies reporting 151 cases of chronic pouchitis were included. The odds of chronic pouchitis were 76% higher in ANCA ‐positive patients than ANCA ‐negative (six studies; OR : 1.76; 95% CI : 1.19–2.61; P < 0.01). ASCA‐positivity was not associated with the risk of chronic pouchitis (three studies; OR : 0.89; 95% CI : 0.49–1.59; P = 0.68). Neither ANCA (eight studies; OR : 1.54; 95% CI : 0.79–3.02; P = 0.21) nor ASCA ‐positivity (two studies; OR : 1.28; 95% CI : 0.25–6.54; P = 0.77) were associated with the risk of acute pouchitis. Conclusions The risk of chronic pouchitis after IPAA is higher in ANCA ‐positive patients, but the risk of acute pouchitis is unaffected by ANCA status. ASCA status was not associated with the risk of acute or chronic pouchitis. This information may be used to counsel UC patients regarding their risk of pouchitis after IPAA .
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
Yab, Tracy C. , Hussain, Fareeda Taher Nazer, Garrity-Park, Megan, Sandborn, William J. , Loftus, Edward V. , Wolff, B. G., Smyrk, Thomas C. , Zou, Hongzhi , Ahlquist, David A. , Kisiel, John B. , Taylor, William R. , Itzkowitz, Steven H. , Rubin, David T. , Mahoney, Douglas W. , Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | January 24, 2013 | Volume: 37 | Issue: 5 | Pages: 546-554

10.1111/apt.12218 | PMID 23347191 Get It

SummaryBackgroundCurrent approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (IBD‐CRN) are suboptimal.AimTo test the feasibility of using stool assay of exfoliated DNA markers to detect IBD‐CRN.MethodsThis investigation comprised tissue and stool studies. In the tissue study, gene sequencing and methylation assays were performed on candidate genes using tissue DNA from 25 IBD‐CRNs and from 25 IBD mucosae without CRN. Mutations on p53, APC, KRAS, BRAF or PIK3CA genes were insufficiently informative, but several aberrantly methylated genes were highly discriminant. In the stool study, we evaluated candidate methylated genes (vimentin, EYA4, BMP3, NDRG4) in a prospective blinded study on buffered stools from 19 cases with known IBD‐CRN and 35 age‐ and sex‐matched IBD controls without CRN. From stool‐extracted DNA, target genes were assayed using quantitative allele‐specific real‐time target and signal amplification method.ResultsIBD‐CRN cases included 17 with ulcerative colitis (UC) and two with Crohn's disease (CD); nine had cancer and 10 had dysplasia. Controls included 25 with UC and 10 with CD. Individually, BMP3, vimentin, EYA4 and NDRG4 markers showed high discrimination in stools with respective areas under the ROC curve of 0.91, 0.91, 0.85 and 0.84 for total IBD‐CRN and of 0.97, 0.97, 0.95 and 0.85 for cancer. At 89% specificity, the combination of BMP3 and mNDRG4 detected 9/9 (100%) of CRC and 80% of dysplasia, 4/4 (100%) of high grade and 4/6 (67%) of low grade.ConclusionThese findings demonstrate the feasibility of stool DNA testing for non‐invasive detection of colorectal neoplasia associated with inflammatory bowel disease.
Geographical variability and environmental risk factors in inflammatory bowel disease
Ng, Siew C. , Bernstein, Çharles N. , Vatn, Morten H., Lakatos, Péter L. , Loftus, Edward V. , Tysk, Curt , O’Morain, Colm, Bernstein, Charles Noah , Moum, Bjørn Allan , Colombel, Jean‐Frédéric , Loftus, Edward V , Ng, Siew C , Lakatos, Peter L

Mayo Clinic

Gut | January 18, 2013 | Volume: 62 | Issue: 4 | Pages: 630-649

10.1136/gutjnl-2012-303661 | PMID 23335431 Get It

The changing epidemiology of inflammatory bowel disease (IBD) across time and geography suggests that environmental factors play a major role in modifying disease expression. Disease emergence in developing nations suggests that epidemiological evolution is related to westernisation of lifestyle and industrialisation. The strongest environmental associations identified are cigarette smoking and appendectomy, although neither alone explains the variation in incidence of IBD worldwide. Urbanisation of societies, associated with changes in diet, antibiotic use, hygiene status, microbial exposures and pollution have been implicated as potential environmental risk factors for IBD. Changes in socioeconomic status might occur differently in different geographical areas and populations and, consequently, it is important to consider the heterogeneity of risk factors applicable to the individual patient. Environmental risk factors of individual, familial, community-based, country-based and regionally based origin may all contribute to the pathogenesis of IBD. The geographical variation of IBD provides clues for researchers to investigate possible environmental aetiological factors. The present review aims to provide an update of the literature exploring geographical variability in IBD and to explore the environmental risk factors that may account for this variability.
Anti‐tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients
Mohabbat, Arya B. , Sandborn, William J. , Loftus, Edward V. , Wiesner, Russell H., Bruining, David H. , Loftus, Edward V

Mayo Clinic

Alimentary Pharmacology & Therapeutics | July 11, 2012 | Volume: 36 | Issue: 6 | Pages: 569-574

10.1111/j.1365-2036.2012.05217.x | PMID 22779779 Get It

SummaryBackgroundUlcerative colitis (UC) and Crohn's disease can sometimes relapse and be refractory to standard treatment following orthotopic liver transplantation (OLT) despite post‐transplantation immunosuppressive therapy.AimTo evaluate the efficacy and safety of anti‐tumour necrosis factor (anti‐TNF) agents for the management of IBD following OLT.MethodsWe reviewed the records of patients with a diagnosis of IBD who underwent OLT at Mayo Clinic Rochester between 1985 and 2009. Patients were included if they had received anti‐TNF therapy post‐OLT. Clinical response was defined as a physician's assessment of improvement after 12 weeks of anti‐TNF usage, and mucosal healing was defined as the absence of ulcerations on follow‐up endoscopy.ResultsThe median age of the eight study patients was 42.0 years and 37.5% were female patients. All had been diagnosed with IBD prior to OLT (UC in three and Crohn's disease in five). Indication for OLT was cirrhotic stage primary sclerosing cholangitis (PSC), and three concomitantly had cholangiocarcinoma. Clinical response was demonstrated in seven of eight patients (87.5%) and mucosal healing was demonstrated in three of seven (42.9%). Four infections (oral candidiasis, Clostridium difficile colitis, bacterial pneumonia and cryptosporidiosis) in three patients were reported. One patient developed an Epstein–Barr virus‐positive post‐transplant lympho‐proliferative disorder. One death occurred due to complications from recurrent PSC.ConclusionsStarting Anti‐TNF therapy following orthotopic liver transplantation appears to be a potential option for inflammatory bowel disease management. Additional studies are needed, however, to confirm these findings and to further assess risks associated with this treatment strategy.
Abstract 3994: Loss of miR-23b enhances Pyk2-induced glioma cell migration and invasion
Paquette, Kimberly , Ross, Julianna T.D., Kloss, Jean , Paulino, Vincent M., Loftus, Joseph C. , Tran, Nhan L. , Nasser, Sara A. , Yang, Zhongbo , Kim, Seungchan , Tran, Nhan L

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 3994-3994

10.1158/1538-7445.am2011-3994 Get It

Abstract Glioblastoma is the most common and lethal type of primary brain tumor. Despite recent therapeutic advances in other cancers, the treatment of glioblastomas remains ineffective and essentially palliative due the highly invasive nature of the disease. To discern molecular mechanisms that drive GBM migration, we investigated the potential role of differential expression of microRNAs (miRNA) by comparing the matched large-scale, genome-wide miRNA expression profiles of migrating and migration-restricted human glioma cells. Using a radial migration assay, migrating and non-migrating populations from seven well-established glioma cell lines were isolated and utilized for miRNA expression analysis. Statistical analyses revealed 22 miRNAs common to all seven glioma cell lines were down-regulated in the migrating cell population (p &lt; 0.0005) relative to cells in the non-migratory population. Specifically, we report here that the expression level of miR-23b was markedly down-regulated in migrating glioma cells as compared to migration-restricted cells. Over-expression of miR-23b significantly inhibited glioma cell migration and invasion. A bioinformatics search revealed a conserved target site within the 3’untranslated region (UTR) of Pyk2, a non-receptor tyrosine kinase that has been previously implicated in the regulation of glioma cell migration and invasion. Increased expression of miR-23b reduced the expression level of Pyk2 in glioma cells indicating that miR-23b targets Pyk2. Notably, increased expression of miR-23b did not alter the expression level of the related focal adhesion kinase FAK indicating that miR-23b specifically inhibits the expression Pyk2. Taken together, our study demonstrates that reduced expression of miR-23b facilitates the enhancement of glioma cell migration and invasion via modulation of Pyk2 expression. Thus, these data suggest that certain miRNAs may regulate glioma migration and invasion to influence the progression of this disease. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3994. doi:10.1158/1538-7445.AM2011-3994
β 1 Integrins Participate in the Hypertrophic Response of Rat Ventricular Myocytes
Ross, Robert S. , Pham, Can G., Shai, Shaw‐Yung, Fenczik, Csilla A., Glembotski, C C, Loftus, Joseph C. , Goldhaber, Joshua I. , Ginsberg, Mark H.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 82 | Issue: 11 | Pages: 1160-1172

10.1161/01.res.82.11.1160 | PMID 9633916 Get It

Abstract —Multiple signaling pathways have been implicated in the hypertrophic response of ventricular myocytes, yet the importance of cell-matrix interactions has not been extensively examined. Integrins are cell-surface molecules that link the extracellular matrix to the cellular cytoskeleton. They can function as cell signaling molecules and transducers of mechanical information in noncardiac cells. Given these properties and their abundance in cardiac cells, we evaluated the hypothesis that β 1 integrin function is involved in the α 1 -adrenergic mediated hypertrophic response of neonatal rat ventricular myocytes. The hypertrophic response of this model required interaction with extracellular matrix proteins. Specificity of these results was confirmed by demonstrating that ventricular myocytes plated onto an anti–β 1 integrin antibody supported the hypertrophic gene response. Adenovirus-mediated overexpression of β 1 integrin augmented the myocyte hypertrophic response when assessed by protein synthesis and atrial natriuretic factor production, a marker gene of hypertrophic induction. DNA synthesis was not altered by integrin overexpression. Transfection of cultured cardiac myocytes with either the ubiquitously expressed β 1A integrin or the cardiac/skeletal muscle–specific β 1 isoform (β 1D ) activated reporter expression from both the atrial natriuretic factor and myosin light chain-2 ventricular promoters, genetic markers of ventricular cell hypertrophy. Finally, suppression of integrin signaling by overexpression of free β 1 integrin cytoplasmic domains inhibited the adrenergically mediated atrial natriuretic factor response. These findings show that integrin ligation and signaling are involved in the cardiac hypertrophic response pathway.